FDA.reportPublic FDA data

dolutegravir 50 MG Oral Tablet [Tivicay]

RxCUI
1433879
RxNorm name
dolutegravir 50 MG Oral Tablet [Tivicay]
Display name
dolutegravir 50 MG Oral Tablet [Tivicay]
Full name
dolutegravir 50 MG Oral Tablet [Tivicay]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TivicayDOLUTEGRAVIR SODIUMST. MARY'S MEDICAL PARK PHARMACY485bc9db-8665-9f5a-e063-6394a90a79212026-05-22Warnings, Adverse reactionsExact identifier
rxcui: 1433879
TivicayDOLUTEGRAVIR SODIUMViiV Healthcare Company63df5af3-b8ac-4e76-9830-2dbb340af9222025-10-29Warnings, Adverse reactionsExact identifier
rxcui: 1433879

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
63df5af3-b8ac-4e76-9830-2dbb340af922Tivicay 50 MG Oral TabletSY31These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320251029
63df5af3-b8ac-4e76-9830-2dbb340af922Tivicay 50 MG (as dolutegravir sodium) Oral TabletSY31These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320251029
63df5af3-b8ac-4e76-9830-2dbb340af922Tivicay 50 MG Oral TabletPSN31These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320251029
63df5af3-b8ac-4e76-9830-2dbb340af922dolutegravir 50 MG Oral Tablet [Tivicay]SBD31These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320251029
b00132b8-58b1-7533-e053-2995a90a0cf1Tivicay 50 MG Oral TabletSY5Tivicay 50mg tab20240718
b00132b8-58b1-7533-e053-2995a90a0cf1Tivicay 50 MG Oral TabletPSN5Tivicay 50mg tab20240718
b00132b8-58b1-7533-e053-2995a90a0cf1dolutegravir 50 MG Oral Tablet [Tivicay]SBD5Tivicay 50mg tab20240718
b00132b8-58b1-7533-e053-2995a90a0cf1Tivicay 50 MG (as dolutegravir sodium) Oral TabletSY5Tivicay 50mg tab20240718
485bc9db-8665-9f5a-e063-6394a90a7921Tivicay 50 MG (as dolutegravir sodium) Oral TabletSY2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320260522
485bc9db-8665-9f5a-e063-6394a90a7921Tivicay 50 MG Oral TabletSY2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320260522
485bc9db-8665-9f5a-e063-6394a90a7921dolutegravir 50 MG Oral Tablet [Tivicay]SBD2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320260522
485bc9db-8665-9f5a-e063-6394a90a7921Tivicay 50 MG Oral TabletPSN2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320260522
44c4bbcc-fe93-4b4b-ad6a-12f46d2354ecTivicay 50 MG Oral TabletPSN2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320230911
44c4bbcc-fe93-4b4b-ad6a-12f46d2354ecdolutegravir 50 MG Oral Tablet [Tivicay]SBD2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320230911
44c4bbcc-fe93-4b4b-ad6a-12f46d2354ecTivicay 50 MG Oral TabletSY2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320230911
44c4bbcc-fe93-4b4b-ad6a-12f46d2354ecTivicay 50 MG (as dolutegravir sodium) Oral TabletSY2These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 201320230911
807b0cd2-093c-4353-a4a5-2e1f264616badolutegravir 50 MG Oral Tablet [Tivicay]SBD1These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 201320190124
807b0cd2-093c-4353-a4a5-2e1f264616baTivicay 50 MG (as dolutegravir sodium) Oral TabletSY1These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 201320190124
807b0cd2-093c-4353-a4a5-2e1f264616baTivicay 50 MG Oral TabletPSN1These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 201320190124
807b0cd2-093c-4353-a4a5-2e1f264616baTivicay 50 MG Oral TabletSY1These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir tablets), for oral use Initial U.S. Approval: 201320190124